ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. The company is headquartered in San Clemente, California and currently employs 13,000 full-time employees. Its product portfolio includes ambulatory, syringe, and large volume intravenous (IV) pumps and safety software, dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, sharps safety products, and sterile IV solutions. Its product offerings also include Consumables, Infusion Systems and Vital Care. Its consumables business unit includes infusion therapy, oncology, vascular access, and tracheostomy products. Its infusion systems offer a portfolio of infusion pumps, software, and professional services. Its vital care business unit includes hemodynamic monitoring, general anesthesia and respiratory, temperature management solutions and regional anesthesia/pain management products. Its infusion therapy products include infusion sets, extension sets, needle-free connectors, and disinfection caps.
Mr. Vivek Jain is the Chairman of the Board of ICU Medical Inc, joining the firm since 2014.
What is the price performance of ICUI stock?
The current price of ICUI is $172.35, it has increased 3.59% in the last trading day.
What are the primary business themes or industries for ICU Medical Inc?
ICU Medical Inc belongs to Health Care industry and the sector is Health Care
What is ICU Medical Inc market cap?
ICU Medical Inc's current market cap is $4.3B
Is ICU Medical Inc a buy, sell, or hold?
According to wall street analysts, 9 analysts have made analyst ratings for ICU Medical Inc, including 4 strong buy, 6 buy, 2 hold, 0 sell, and 4 strong sell